C12N 2760/18061
Methods of inactivation or attenuation
C12N2760/18061 (Methods of inactivation or attenuation) appears on 5 US grants and 11 published applications in this corpus.
Search patents in C12N- Granted patents
- 5
- Published applications
- 11
- Assignees
- 5
- Inventors
- 14
- Latest grant
- 22 Jan 2019
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2007 | 1 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 1 | 1 |
| 2016 | 2 | 1 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 1 |
| 2025 | 0 | 2 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methods for viral inactivation and other adventitious agents22 Jan 2019US 10,184,106 B2Genentech, Inc.
- Methods for viral inactivation and other adventitious agents15 Nov 2016US 9,493,744 B2Genentech, Inc.
- Pan-antiviral peptides and uses thereof19 Jul 2016US 9,393,286 B2Nuovo Biologics, LLC
- Pan-antiviral peptides27 Jan 2015US 8,940,867 B2Nuovo Biologics, LLC
- Pan-antiviral peptides21 Aug 2007US 7,259,237 B1
- Virus attenuation30 Apr 2026US 2026/0115273 A1University of Lancaster
- Recombinant live attenuated rsv vaccine strain and production method therefor24 Apr 2025US 2025/0127872 A1SK Bioscience Co., Ltd.
- Methods for viral inactivation and other adventitious agents3 Apr 2025US 2025/0109376 A1Genentech, Inc.
- Methods for viral inactivation and other adventitious agents19 Sep 2024US 2024/0309314 A1Genentech, Inc.
- Methods for viral inactivation and other adventitious agents25 May 2023US 2023/0159886 A1Genentech, Inc.
Most cited
By later US patents